TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23769665

Group type: EXPERIMENTAL
Intervention: Blastocyst cryopreservation
Number of subjects: 1190

Group type: COMPARATOR
Intervention: Cleavage-stage embryo cryopreservation (control group)
Number of subjects: 1190
Study: 21612749

Group type: EXPERIMENTAL
Intervention: Risperidone GPO® (Test)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Risperdal® (Reference)
Number of subjects: 23
Study: 18637935

Group type: EXPERIMENTAL
Intervention: PTQ (injectable silicone biomaterial)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Durasphere (carbon-coated beads)
Number of subjects: 40
Study: 17925114

Group type: EXPERIMENTAL
Intervention: Cyclofem
Number of subjects: 68

Group type: COMPARATOR
Intervention: DMPA
Number of subjects: 68
Study: 15089817

Group type: EXPERIMENTAL
Intervention: Nifedipine controlled-release (CR) 20-40 mg daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nifedipine retard 20-40 mg daily
Number of subjects: 25
Study: 11386476

Group type: EXPERIMENTAL
Intervention: Methylphenidate (Ritalin)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 8703451

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 41

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 41
Study: 1286640

Group type: EXPERIMENTAL
Intervention: Nicotiana tabacum (snuff) with Natron 0.5g/100g
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nicotiana tabacum (snuff) with Natron 10g/100g
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nicotiana tabacum (snuff) without Natron
Number of subjects: 33
Study: 3931910

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No selenium supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cardiac enzyme activity measurement
Number of subjects: 0
Study: 31680225

Group type: EXPERIMENTAL
Intervention: Yoga practice for 1 hour, 2 times a week for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (untreated with yoga, given lung rehabilitation brochure)
Number of subjects: 30
Study: 30537959

Group type: EXPERIMENTAL
Intervention: Lexical approach to identifying inconsistencies in SNOMED CT modeling
Number of subjects: 50
Study: 27471813

Group type: EXPERIMENTAL
Intervention: D (Dentistar)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: N (NUK)
Number of subjects: 121

Group type: COMPARATOR
Intervention: C (no pacifier)
Number of subjects: 121
Study: 24697870

Group type: EXPERIMENTAL
Intervention: Recombinant factor IX (Bax326)
Number of subjects: 14
Study: 23705344

Group type: EXPERIMENTAL
Intervention: Multimodal Music Therapy (MMT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 36
Study: 18469160

Group type: EXPERIMENTAL
Intervention: MBSR-ld
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control
Number of subjects: 42
Study: 17845588

Group type: EXPERIMENTAL
Intervention: Xolair (omalizumab) treatment for 6 years followed by withdrawal
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Xolair withdrawal
Number of subjects: 18
Study: 16329362

Group type: EXPERIMENTAL
Intervention: Bilateral sequential LASIK
Number of subjects: 335

Group type: COMPARATOR
Intervention: Bilateral simultaneous LASIK
Number of subjects: 335
Study: 12488405

Group type: EXPERIMENTAL
Intervention: Goserelin plus Tamoxifen (3 years of goserelin plus 5 years of tamoxifen)
Number of subjects: 1034

Group type: COMPARATOR
Intervention: Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) (six cycles)
Number of subjects: 1034
Study: 9798529

Group type: EXPERIMENTAL
Intervention: ANP (7.5 ng/kg/min) infusion during high salt diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo during high salt diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ANP infusion during low salt diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo during low salt diet
Number of subjects: 20
Study: 8566922

Group type: EXPERIMENTAL
Intervention: Graphite furnace atomic absorption spectrophotometry (GFAAS) method for manganese determination
Number of subjects: 1
Study: 2611070

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 57815

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 14
Study: 31775780

Group type: EXPERIMENTAL
Intervention: EMG-based biofeedback device
Number of subjects: 14

Group type: COMPARATOR
Intervention: No biofeedback device (control)
Number of subjects: 14
Study: 27524737

Group type: EXPERIMENTAL
Intervention: Transcutaneous interferential electrical stimulation plus behavioral therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Behavioral therapy alone
Number of subjects: 30
Study: 25794202

Group type: EXPERIMENTAL
Intervention: 5 mL of lidocaine 2%
Number of subjects: 57

Group type: COMPARATOR
Intervention: 4 mL of lidocaine 2% + 1 mL of betametazone
Number of subjects: 57
Study: 22776698

Group type: EXPERIMENTAL
Intervention: Ramped methodology
Number of subjects: 10

Group type: COMPARATOR
Intervention: Random methodology
Number of subjects: 10
Study: 20537740

Group type: EXPERIMENTAL
Intervention: Aerosolized iloprost (n = 50)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intravenous adenosine (n = 25)
Number of subjects: 75
Study: 19643961

Group type: EXPERIMENTAL
Intervention: Custom‐designed soft contact lenses with altered ocular SA to ‐0.10 microm
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Vision training regimen for 18 minutes per day for up to 6 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control groups had contact lenses with no added SA and/or no exercises
Number of subjects: 93
Study: 17236861

Group type: EXPERIMENTAL
Intervention: Suturing in full complexity under 2-dimensional conditions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Simple cone transfer drills under 3-dimensional and then 2-dimensional conditions, followed by suturing under 3-dimensional and then 2-dimensional conditions
Number of subjects: 24
Study: 15533855

Group type: EXPERIMENTAL
Intervention: Azimilide 75 mg
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Azimilide 125 mg
Number of subjects: 633

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 633
Study: 10642679

Group type: EXPERIMENTAL
Intervention: Erythromycin (divided doses for 14 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 9050958

Group type: EXPERIMENTAL
Intervention: Temporal lobe oriented computed tomography (CT)
Number of subjects: 333
Study: 8156249

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy regimen 1
Number of subjects: 127

Group type: COMPARATOR
Intervention: Combination chemotherapy regimen 2
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Overall quality of life assessment
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Multiple regression analysis
Number of subjects: 127
Study: 2423794

Group type: EXPERIMENTAL
Intervention: Indoramin (75 mg/day for 2 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31836594

Group type: EXPERIMENTAL
Intervention: Auricular acupressure using Semen Vaccariae (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Auricular acupressure using magnetic beads (Group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine care (Group C)
Number of subjects: 100
Study: 31691305

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Return-to-Work Intervention (RTW-I)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Combination of CBT and RTW-I (COMBO)
Number of subjects: 152
Study: 28422520

Group type: EXPERIMENTAL
Intervention: LLLT-135 J
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: LLLT-270 J
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: LLLT-405 J
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 28395886

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF)
Number of subjects: 3385
Study: 25777187

Group type: EXPERIMENTAL
Intervention: rilpivirine/emtricitabine/tenofovir DF (RPV/FTC/TDF)
Number of subjects: 786

Group type: COMPARATOR
Intervention: efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF)
Number of subjects: 786
Study: 24241787

Group type: EXPERIMENTAL
Intervention: Tamoxifen 5 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenretinide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both agents (Tamoxifen and Fenretinide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SHBG levels
Number of subjects: 0
Study: 21178084

Group type: EXPERIMENTAL
Intervention: 2 g/d of algal DHA
Number of subjects: 36
Study: 18509560

Group type: EXPERIMENTAL
Intervention: SEAS exercises
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 74
Study: 16921042

Group type: EXPERIMENTAL
Intervention: Maintenance paclitaxel
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control (no additional chemotherapy)
Number of subjects: 255
Study: 12656936

Group type: EXPERIMENTAL
Intervention: Right prefrontal TMS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 25
Study: 10634672

Group type: EXPERIMENTAL
Intervention: Left Ventricular Assist Device (LVAD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Heart transplantation without LVAD (Control)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Non-heart failure controls (Autopsy hearts)
Number of subjects: 8
Study: 8944192

Group type: EXPERIMENTAL
Intervention: BrAC 0.1%
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: BrAC 0.05%
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 1758414

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration therapy using a resorbable membrane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guided tissue regeneration therapy using a nonresorbable membrane
Number of subjects: 0
Study: 7045255

Group type: EXPERIMENTAL
Intervention: Topical 5% acyclovir (ACV) in polyethylene glycol (PEG)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 30012431

Group type: EXPERIMENTAL
Intervention: Tofacitinib (10 mg twice daily, n = 905)
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Placebo (n = 234)
Number of subjects: 1139
Study: 27154976

Group type: EXPERIMENTAL
Intervention: Iloprost infusion plus standardized protocol of peroneal nerve electrostimulation (1 Hz frequency, 27 mA current, 200 ms pulse width)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Iloprost infusion protocol alone
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (Iloprost infusion alone and Iloprost infusion plus electrostimulation)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study: 26370136

Group type: EXPERIMENTAL
Intervention: Aclidinium (400 μg, bd)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study: 23581798

Group type: EXPERIMENTAL
Intervention: Pinpoint irradiation technique by CO2 laser without needling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pinpoint irradiation technique by CO2 laser with needling
Number of subjects: 60
Study: 21707679

Group type: EXPERIMENTAL
Intervention: ANA773 2000mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: ANA773 1600mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: ANA773 1200mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: ANA773 800mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 19628104

Group type: EXPERIMENTAL
Intervention: Waxy maize starch (WM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Maltodextrin-sucrose mixture (MS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: White bread (control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Postprandial energy expenditure and appetite
Number of subjects: 12
Study: 16924341

Group type: EXPERIMENTAL
Intervention: Ozone applied to ultrasonic cleaning system with sterile distilled water
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Ozone applied to ultrasonic cleaning system with vinegar
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Ozone applied to ultrasonic cleaning system with sterile distilled water + Endozime AWpluz
Number of subjects: 1
Study: 14685870

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (0.3 g/kg per day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 11986017

Group type: EXPERIMENTAL
Intervention: Active mechanical massage by intermittent negative pressure on the abdominal wall (Cellu M50 device, LPG, Valence, France); performed daily until the seventh postoperative day.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo group (no active mechanical massage); ineffective parameters used.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Active mechanical massage group; performed daily until the seventh postoperative day.
Number of subjects: 50
Study: 9876753

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide
Number of subjects: 85

Group type: COMPARATOR
Intervention: Prophylactic treatment (ondansetron or metoclopramide) in males
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Prophylactic ondansetron in females
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Prophylactic metoclopramide in females
Number of subjects: 85
Study: 8541815

Group type: EXPERIMENTAL
Intervention: Ambroxol, 150 mg.day‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ambroxol
Number of subjects: 20
Study: 2121104

Group type: EXPERIMENTAL
Intervention: 0.01 mg of recombinant human IFN‐gamma
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.1 mg of recombinant human IFN‐gamma
Number of subjects: 8

Group type: COMPARATOR
Intervention: Diluent alone (control)
Number of subjects: 8
Study: 750151

Group type: EXPERIMENTAL
Intervention: Ingestion of hyperosmotic solutions made with glycerol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with coeliac disease
Number of subjects: 0
Study: 7083658

Group type: EXPERIMENTAL
Intervention: Surgical intervention (excision arthroplasty of the forefoot)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Non-operative management
Number of subjects: 65
Study: 31264085

Group type: EXPERIMENTAL
Intervention: Biophysical therapy (electromagnetic information transfer through aqueous system procedure every 3 months)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Control (standard treatment with renin‐angiotensin‐aldosterone system inhibitors)
Number of subjects: 238
Study: 29405515

Group type: EXPERIMENTAL
Intervention: BCG-PSN therapy (intradermal injections, twice weekly for three weeks)
Number of subjects: 24
Study: 26332798

Group type: EXPERIMENTAL
Intervention: 25% caloric restriction (CR group, n = 143)
Number of subjects: 218
Study: 24796339

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Delcasertib 50 mg/h
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Delcasertib 150 mg/h
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Delcasertib 450 mg/h
Number of subjects: 1010
Study: 21959687

Group type: EXPERIMENTAL
Intervention: 3D navigation (Group II)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard navigation (Group I)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 19849677

Group type: EXPERIMENTAL
Intervention: Parker Flex-Tip tracheal tube
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional tip tracheal tube
Number of subjects: 102
Study: 17663098

Group type: EXPERIMENTAL
Intervention: Scalp-acupuncture plus body-acupuncture combined with body therapy and performance therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Simple body therapy and performance therapy
Number of subjects: 80
Study: 16566082

Group type: EXPERIMENTAL
Intervention: Enfuvirtide
Number of subjects: 995

Group type: COMPARATOR
Intervention: Non-enfuvirtide
Number of subjects: 995
Study: 12147961

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE) guided cardioversion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional practice of prolonged anticoagulation prior to cardioversion
Number of subjects: 0
Study: 10409573

Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex) treatment at doses of 0.5 mg and 1.5 mg administered twice daily for 4.5 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise bout at maximal O(2) consumption
Number of subjects: 0
Study: 7749447

Group type: EXPERIMENTAL
Intervention: Sandbag applied to the femoral site
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Sheet over the affected leg and tucked under the mattress
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Verbal instruction to keep the leg straight and still
Number of subjects: 300
Study: 2134529

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 6994477

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Narcotic medications
Number of subjects: 15
Study: 31643039

Group type: EXPERIMENTAL
Intervention: Prasugrel 2.5 mg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Prasugrel 5 mg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Prasugrel 7.5 mg
Number of subjects: 66

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Prasugrel 5 mg and 7.5 mg (CYP2C19 intermediate metabolizers)
Number of subjects: 66
Study: 30895320

Group type: EXPERIMENTAL
Intervention: Monounsaturated omega-9 (MUFA n-9) diet
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Polyunsaturated omega-3 (PUFA n-3) diet
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control diet (SFA)
Number of subjects: 200
Study: 28851504

Group type: EXPERIMENTAL
Intervention: Bioresorbable polymer sirolimus-eluting stents
Number of subjects: 1334

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stents
Number of subjects: 1334
Study: 25812823

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.2 mg daily for 7 days)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (prostate biopsy only)
Number of subjects: 88
Study: 23602132

Group type: EXPERIMENTAL
Intervention: SWS suppression
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: REM-sleep disturbance
Number of subjects: 16

Group type: COMPARATOR
Intervention: Regular sleep
Number of subjects: 16
Study: 21719902

Group type: EXPERIMENTAL
Intervention: Ad libitum ingestion of water (W)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ad libitum ingestion of a commercial 8% carbohydrate-electrolyte sports beverage (CSB)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No fluid ingestion allowed (NF)
Number of subjects: 12
Study: 19944359

Group type: EXPERIMENTAL
Intervention: FDC I/H
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Baseline MLHFQ score
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Change in MLHFQ score at 3 months
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Change in MLHFQ score at 6 months
Number of subjects: 1050
Study: 17720079

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of triamcinolone acetonide (4 mg/0.1 mL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral steroids (steroid group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of triamcinolone acetonide
Number of subjects: 40
Study: 15155466

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) monotherapy (serum concentrations 346‐693 microM [50‐100 microg/mL])
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) + all-trans retinoic acid (ATRA) (80 mg/m(2)/d, days 1‐7, every other week)
Number of subjects: 18
Study: 11559644

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 or 40 mg daily)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Open antireflux surgery (ARS)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Both interventions (Omeprazole and ARS)
Number of subjects: 298
Study: 9040553

Group type: EXPERIMENTAL
Intervention: High fiber diets (fruits and vegetables)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High fiber diets (citrus fiber)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High fiber diets (barley fiber at high protein intake)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High fiber diets (barley fiber at low protein intake)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High fiber diets (coarse whole meal rye bread)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High fiber diets (fine whole meal rye bread)
Number of subjects: 0
Study: 7956638

Group type: EXPERIMENTAL
Intervention: Diabetic group (n=80)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Nondiabetic group (n=81)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 161
Study: 3312553

Group type: EXPERIMENTAL
Intervention: Heparin (low doses)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control (no heparin)
Number of subjects: 111
Study: 31444663

Group type: EXPERIMENTAL
Intervention: Iron therapy ± red blood cell transfusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: IDAT cases
Number of subjects: 10

Group type: COMPARATOR
Intervention: ITP controls
Number of subjects: 10
Study: 26582873

Group type: EXPERIMENTAL
Intervention: MMR-RIT-1 (4.8 log10 CCID50)
Number of subjects: 1220

Group type: EXPERIMENTAL
Intervention: MMR-RIT-2 (4.1 log10 CCID50)
Number of subjects: 1220

Group type: EXPERIMENTAL
Intervention: MMR-RIT-3 (3.7 log10 CCID50)
Number of subjects: 1220

Group type: COMPARATOR
Intervention: MMRII co-administered with HAV, VAR, and PCV7
Number of subjects: 1220

Group type: EXPERIMENTAL
Intervention: All groups (MMR-RIT lots and MMRII)
Number of subjects: 1220
Study: 24157526

Group type: EXPERIMENTAL
Intervention: Active exercise
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Passive movement
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control subjects (healthy)
Number of subjects: 21
Study: 21593108

Group type: EXPERIMENTAL
Intervention: Mitochondrial mass and ATP synthesis in myotubes from PCOS subjects
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control subjects (healthy weight- and age-matched)
Number of subjects: 16